Summary of Purpose
This study evaluates the neuromodulatory effect of combined tDCS and aphasia therapy in patients in the chronic phase after stroke. Half of the participants will receive aphasia therapy and tDCS, the other half will receive aphasia therapy and sham-tDCS.Read More →
The following dates are available for this trial. Trial information last updated on 9 October 2017.
|1 Nov 2017||28 Sep 2017||1 Oct 2021||1 Oct 2021||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Elien De Cock
firstname.lastname@example.org +32(0)478 21 37 84